Biocartis’ KRAS Mutation Test Receives CE-IVD Marking

Product News   Jun 24, 2015

 
Biocartis’ KRAS Mutation Test Receives CE-IVD Marking
 
 
FURTHER INFORMATION
 
 
 

Related Product News

DiaSorin Molecular Receives FDA Clearance for Reliable C. difficile Assay on LIAISON MDX Platform

Product News

Simplexa C. difficile Direct Assay is a benchtop instrument that detects the Clostridium difficile toxin B gene present in liquid or unformed stool samples, aiding in the diagnosis of C. difficile infection.

READ MORE

CD47 Protein Products for Cancer & Cardiovascular Research

Product News

CD47 is a transmembrane protein and key regulator of tissue homeostasis involved in a variety of diseases ranging from atherosclerosis to cancer.

READ MORE

PerkinElmer Extends Clinical Whole Genome Sequencing Services

Product News

PerkinElmer partners with ViaCord to expand on its recent introduction of clinical Whole Genome Sequencing services.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE